Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: The purpose of this study was to summarize published estimates for conversion from mild cognitive impairment or amnestic mild cognitive impairment to Alzheimer's dementia. We carried out a systematic review of English language publications to identify cohort studies published since January 2006 that reported the risk or rate of conversion. Summary: Thirty-two cohort studies were identified, of which 14 reported annualized conversion rates (ACRs). Conversions over 1 year ranged from 10.2 to 33.6% (5 studies, median: 19.0%), and over 2 years from 9.8 to 36.3% (7 studies, median: 18.6%). ACRs ranged from 7.5 to 16.5% (7 studies, median: 11.0%) per person-year for studies recruiting from clinics, and from 5.4 to 11.5% (7 studies, median: 7.1%) for community samples. Key Message: Extensive variation was observed in conversion rates due to the population sampled, diagnostic criteria, and duration, and because many studies did not account for loss to follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one-third develop dementia due to Alzheimer's within five years.52”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one‐third develop dementia due to Alzheimer's within five years.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Self-citation
Cited by
Items 401–427 of 427
Gürlek, E., & Gökbay, İ. Z. (2026) · Neural Computing and Applications · doi:10.1007/s00521-026-12022-1
“…assessment: The focus must move from cross-sectional diagnosis to prediction of disease progression (e.g., MCI-to-AD within a 2-year follow-up period, conversion rates have been reported to range between 9.8 and 36.3% [76]), which is the most clinically impactful application for intervention.”
InfluentialChoi, H. J., Cho, A. J., You, J. H., Park, S., Lee, S. R., & Kim, D. H. (2026) · Medicina · doi:10.3390/medicina62030529
“MCI affects approximately 10–15% of individuals aged ≥ 65 years, with an annual conversion rate to AD of 10–15% [4–7].”
Županič, E., Stegnar, G., Rakuša, M., Prelog, P. R., Švab, I., & Kramberger, M. G. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261424524
Quality Improvement in a Community-Based Dementia Clinic
Jacobson, K., Onesko, L., Knox, L., & Cleveland, K. (2026) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2026.105731
Yang, L., Song, G., Parker, E., & Yang, L. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05832-w
Moreau, N. (2015) · theses.fr (ABES) · doi:10.70675/a7613071ze510z43d2z9da9za07753710845
Développement de formes vectorisables innovantes dans le cadre de maladies liées à l'âge
Iskandar, S. (2019) · theses.fr (ABES) · doi:10.70675/1d771122z75d0z4ba8z8ee6zbd1a858ffc38
Célestine, M. (2023) · theses.fr (ABES) · doi:10.70675/873ca377z9a97z43f6z8051zdab4082686ba · Cited by 1
How exercise improves Alzheimer's disease
Niu, Y.-M. (2023) · Integrate Medicine · doi:10.61958/imkk9385
Rashidi‐Ranjbar, N., Churchill, N. W., Jerkić, M., Zomorrodi, R., Rotstein, O. D., Schneider, R., Andreazza, A. C., Rajji, T. K., Graham, S. J., Munoz, D. G., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261453911 · Cited by 1
Zhu, X., Wang, C., Cao, Q., Xu, Q., Guo, X., & Liu, C. (2026) · Medicine · doi:10.1097/md.0000000000049278
Serra, L., Mancini, M., Bonarota, S., Caruso, G., Domenico, C. D., Rizzuti, M., Lorenzo, F. D., Mencarelli, L., Koch, G., Caltagirone, C., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.06.009
Weitzner, D. S., Boscarino, J. J., Vanderbleek, E. N., Babicz, M. A., Seidl, J. N. T., Hurin, G., & Kamper, J. E. (2026) · Applied Neuropsychology Adult · doi:10.1080/23279095.2026.2695321
Lan, S., Du, J., Xu, Y., Wang, S., Zhang, Y., Yuan, R., Lv, Y., Ding, L., Jin, Y., Ren, Y., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06019-z
“Statistics reveal that between 15 and 20% of the elderly population over the age of 65 in China experience mild cognitive impairment, with 32% of these individuals progressing to Alzheimer's disease within a five-year period [3].”
Lim, S., Lee, Y., Yun, C., Kim, K., Yun, C., & Initiative, A. D. N. (2026) · Annals of Neurology · doi:10.1002/ana.78301
Xie, Z., Locke, D. E. C., Shandera-Ochsner, A., Hamadi, H. Y., Wit, L. D., Santos, O., Boots, E. A., Aghamoosa, S., Grant, J., Smith, G. E., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261471921
Leme, D. E. D. C., Lustria, M. L. A., Carr, D. C., Charness, N. H., Langa, K. M., & He, Z. (2026) · Journal of Aging and Health · doi:10.1177/08982643261475378
Kristiansen, S., Eriksen, S., Trevino, C. S., Välimäki, T. H., Atladóttir, H., Gudmundsdottir, G., Engedal, K., Snædal, J., Rokstad, A. M. M., & Konradsen, H. (2026) · Geriatric Nursing · doi:10.1016/j.gerinurse.2026.104209
AI-aided neuroimaging for the diagnosis of Alzheimer's disease: A concise review of recent studies
Lee, Y., Nadalin, P., Onemli, E., Hadad, R., Yu, F., Greenbaum, L., Greenbaum, A., & Ahn, J. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45308
Kandiah, N., Chan, Y. F., Dasig, D., Dominguez, J. C., Koh, K. C., Lim, S. C., Ong, P. A., Ampil, E. R., Seet, R. C. S., Senanarong, V., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71085
椎野, 顯., Kitahara, H., 井藤, 隆., Syaifullah, A. H., Shiino, A., Itoh, R., Ishida, M., & Tanigaki, K. (2021) · Institutional Repositories DataBase (IRDB)
Sari, K., Kouchaki, S., & Abásolo, D. (2026) · Entropy · doi:10.3390/e28091034
“Approximately 10–15% of MCI patients convert to AD each year [6]; furthermore, long-term follow-up studies have reported that this conversion rate increases over time, with approximately 33% of patients converting to AD within 5 years [7].”
Li, Y., Zhang, M., Ying, C., Han, C., Li, Q., & Cai, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1727449
“…mild cognitive impairment (aMCI) is recognized as a prodromal stage of AD, with an annual conversion rate to AD of 11.0% − 16.5%, and is considered a critical window for early intervention between normal aging and clinical dementia (Ward et al., 2013; Cong et al., 2023; Abu-Rumeileh et al., 2024).”
InfluentialNguyen, K. Q., Than, T. H. N., & To, K. G. (2026) · Research Square · doi:10.21203/rs.3.rs-10753972/v1
Mendes, Y. D., Clua, E. W., Costa, R. Q. M., Pompeu, J. E., de Campos, L. M. S., Magalhães, J., Porcino, T. M., & da Silva, E. M. (2026) · Simpósio Brasileiro de Jogos e Entretenimento Digital (SBGames) · doi:10.5753/sbgames.2026.25653
“MCI describes a clinical state between expected cognitive aging and dementia [Petersen et al. 2014]; the amnestic subtype is associated with increased risk of progression to Alzheimer’s disease dementia [Ward et al. 2013, Petersen et al. 2014].”
Bai, X., Ji, Y., Ruan, H., Zhang, W., Ma, Y., Jiang, X., Liu, X., & Wang, F. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1977763
Metadata
- Authors
- Ward, A., Tardiff, S., Dye, C., & Arrighi, H. M.
- Affiliations
- Janssen Alzheimer Immunotherapy Research & Development (United States) (US)
- Corresponding author
- Arrighi, H. Michael
- ORCID
- Ward, Alex
- Venue
- Dementia and Geriatric Cognitive Disorders Extra
- Publisher
- S. Karger AG
- Published
- 2013-09-28
- Volume
- 3
- Issue
- 1
- Pages
- 320-332
- ISSN
- 1664-5464 (ISSN-L)
- PMC
- PMC3808216
- OpenAlex
- W2010643121
- Cited by
- 426
- References
- 68
- Citations by year
- 2026: 28 · 2025: 47 · 2024: 64 · 2023: 61 · 2022: 44 · 2021: 60 · 2020: 32 · 2019: 30 · 2018: 26 · 2017: 5 · 2016: 14 · 2015: 11 · 2014: 4
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders Extra (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- prodromal Alzheimer's disease, Alzheimer's dementia, conversion rate, mild cognitive impairment, amnestic mild cognitive impairment, cohort studies, loss to follow-up, diagnostic criteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
